Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
O'Neill Gilmore Neil
CEO at Editas Medicine. Filing since 5 Jun 2023.
CIK 0001742084
Company
Date
Role
Action
Shares
Amount
Of holding
EDIT
Editas Medicine, Inc.
3 Sep 2026
CEO
Sold on a plan
5,124
$15.56K
2.1%
EDIT
Editas Medicine, Inc.
3 Jun 2026
CEO
Sold on a plan
15,380
$41.54K
5.8%
EDIT
Editas Medicine, Inc.
3 Mar 2026
CEO
Sold on a plan
5,394
$10.89K
2.0%
EDIT
Editas Medicine, Inc.
3 Dec 2025
CEO
Sold on a plan
5,603
$12.06K
2.0%
EDIT
Editas Medicine, Inc.
3 Sep 2025
CEO
Sold on a plan
5,592
$14.52K
2.0%
EDIT
Editas Medicine, Inc.
3 Jun 2025
CEO
Sold on a plan
15,192
$26.20K
5.1%
EDIT
Editas Medicine, Inc.
4 Mar 2025
CEO
Sold on a plan
16,632
$28.45K
5.3%
EDIT
Editas Medicine, Inc.
3 Dec 2024
CEO
Sold on a plan
1,618
$3.36K
0.5%
EDIT
Editas Medicine, Inc.
4 Sep 2024
CEO
Sold on a plan
1,555
$5.33K
0.5%
EDIT
Editas Medicine, Inc.
4 Jun 2024
CEO
Sold on a plan
12,191
$67.00K
3.7%
EDIT
Editas Medicine, Inc.
5 Mar 2024
CEO
Sold on a plan
77,824
$732.88K
19.2%
EDIT
Editas Medicine, Inc.
5 Jun 2023
CEO
Sold on a plan
6,486
$61.64K
4.7%
12 decisions on file.
